Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > dayanpantig01.....New Pumper Account

<< Previous

Bullboard Posts

Next >>

Comment by Renofundon Dec 22, 2020 9:09am

63 Views

Post# 32159623

RE:RE:RE: dayanpantig01.....New Pumper Account

pdelics21 wrote: https://www.clinicaltrialsarena.com/news/fsd-pharma-dosing-trial/

They are in very good position and we just need to be patient and this is a sure-fire win in the future.

The trial’s secondary objectives are analysing whether FSD201 plus SOC shows additional benefit in terms of safety, objective assessments such as time taken to normalisation of fever, time taken for improving oxygen saturation and time to clinical progression.

hear that folks? It is a "SURE-FIRE win in the future" LOL.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China